11 years of historical data (2015–2025) · Healthcare · Medical - Instruments & Supplies
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
Alcon Inc. trades at 32.9x earnings, 51% below its 5-year average of 67.3x, sitting at the 0th percentile of its historical range. Compared to the Healthcare sector median P/E of 22.1x, the stock trades at a premium of 49%. On a free-cash-flow basis, the stock trades at 18.4x P/FCF, 80% below the 5-year average of 91.4x.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $31.8B | $39.1B | $42.2B | $38.8B | $33.9B | $43.0B | $32.3B | $27.6B | — | — | — |
| Enterprise Value | $35.5B | $42.8B | $45.7B | $42.8B | $38.0B | $45.9B | $35.2B | $30.6B | — | — | — |
| P/E Ratio → | 32.92 | 39.80 | 41.41 | 39.86 | 100.81 | 114.63 | — | — | — | — | — |
| P/S Ratio | 3.05 | 3.76 | 4.26 | 4.10 | 3.89 | 5.18 | 4.72 | 3.68 | — | — | — |
| P/B Ratio | 1.47 | 1.77 | 1.96 | 1.88 | 1.72 | 2.23 | 1.71 | 1.43 | — | — | — |
| P/FCF | 18.38 | 22.63 | 30.02 | 72.23 | 71.80 | 260.52 | 126.03 | 113.19 | — | — | — |
| P/OCF | 13.99 | 17.22 | 20.33 | 27.94 | 27.85 | 31.96 | 39.20 | 30.02 | — | — | — |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
Alcon Inc.'s enterprise value stands at 13.9x EBITDA, 30% below its 5-year average of 19.8x. This is roughly in line with the Healthcare sector median of 14.2x.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 4.12 | 4.61 | 4.53 | 4.36 | 5.53 | 5.15 | 4.08 | — | — | — |
| EV / EBITDA | 13.91 | 16.79 | 17.30 | 18.95 | 20.73 | 25.47 | 28.36 | 23.99 | — | — | — |
| EV / EBIT | 26.09 | 36.92 | 31.55 | 41.95 | 61.60 | 85.11 | — | — | — | — | — |
| EV / FCF | — | 24.78 | 32.47 | 79.75 | 80.46 | 278.12 | 137.51 | 125.41 | — | — | — |
Margins and return-on-capital ratios measuring operating efficiency
Alcon Inc. earns an operating margin of 13.1%. Operating margins have expanded from 11.0% to 13.1% over the past 3 years, signaling improving operational efficiency. ROE of 4.5% is modest. ROIC of 4.0% represents below-average returns on invested capital.
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 55.2% | 55.2% | 55.6% | 55.5% | 54.5% | 56.1% | 43.0% | 48.8% | 44.6% | 47.2% | 47.2% |
| Operating Margin | 13.1% | 13.1% | 14.3% | 11.0% | 7.7% | 7.0% | -7.1% | -2.5% | -3.5% | -1.1% | 0.2% |
| Net Profit Margin | 9.4% | 9.4% | 10.3% | 10.3% | 3.8% | 4.5% | -7.8% | -8.7% | -3.2% | 3.8% | -2.6% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 4.5% | 4.5% | 4.8% | 4.8% | 1.7% | 2.0% | -2.8% | -3.1% | -1.0% | 1.1% | -0.7% |
| ROA | 3.2% | 3.2% | 3.4% | 3.3% | 1.2% | 1.4% | -1.9% | -2.4% | -0.8% | 0.9% | -0.6% |
| ROIC | 4.0% | 4.0% | 4.3% | 3.2% | 2.2% | 2.0% | -1.6% | -0.6% | -0.8% | -0.3% | 0.0% |
| ROCE | 4.8% | 4.8% | 5.1% | 3.9% | 2.6% | 2.3% | -1.9% | -0.7% | -1.0% | -0.3% | 0.0% |
Solvency and debt-coverage ratios — lower is generally safer
Alcon Inc. carries a Debt/EBITDA ratio of 2.1x, which is manageable (36% below the sector average of 3.2x). Net debt stands at $3.7B ($5.2B total debt minus $1.5B cash).
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.24 | 0.24 | 0.24 | 0.25 | 0.26 | 0.23 | 0.24 | 0.20 | 0.01 | 0.01 | 0.01 |
| Debt / EBITDA | 2.06 | 2.06 | 1.94 | 2.27 | 2.77 | 2.49 | 3.62 | 2.98 | 0.10 | 0.12 | 0.20 |
| Net Debt / Equity | — | 0.17 | 0.16 | 0.20 | 0.21 | 0.15 | 0.16 | 0.15 | -0.00 | -0.00 | 0.00 |
| Net Debt / EBITDA | 1.46 | 1.46 | 1.31 | 1.79 | 2.23 | 1.61 | 2.37 | 2.34 | -0.07 | -0.02 | 0.07 |
| Debt / FCF | — | 2.15 | 2.45 | 7.53 | 8.66 | 17.60 | 11.48 | 12.22 | -0.21 | -0.03 | 0.12 |
| Interest Coverage | — | — | 7.78 | 5.40 | 4.46 | 4.48 | -4.12 | -1.53 | -11.50 | -3.74 | -2.73 |
Short-term solvency ratios and asset-utilisation metrics
Alcon Inc.'s current ratio of 2.12x is well above the 1.0 safety threshold, indicating strong short-term liquidity with ample room to cover current liabilities. The quick ratio of 1.33x is notably lower than the current ratio, indicating a significant portion of current assets is tied up in inventory. The current ratio has declined from 2.35x to 2.12x over the past 3 years.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.12 | 2.12 | 2.77 | 2.35 | 1.90 | 2.18 | 2.21 | 1.84 | 1.80 | 1.85 | 1.81 |
| Quick Ratio | 1.33 | 1.33 | 1.77 | 1.39 | 1.13 | 1.41 | 1.48 | 1.19 | 1.03 | 1.12 | 1.09 |
| Cash Ratio | 0.53 | 0.53 | 0.80 | 0.46 | 0.36 | 0.64 | 0.69 | 0.37 | 0.14 | 0.10 | 0.10 |
| Asset Turnover | — | 0.33 | 0.33 | 0.32 | 0.30 | 0.30 | 0.25 | 0.27 | 0.26 | 0.25 | 0.24 |
| Inventory Turnover | 1.95 | 1.95 | 1.94 | 1.81 | 1.88 | 1.92 | 2.37 | 2.56 | 2.75 | 2.75 | 2.89 |
| Days Sales Outstanding | — | 68.15 | 76.68 | 72.81 | 83.28 | 70.13 | 78.42 | 73.51 | 71.74 | 81.58 | 77.64 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Alcon Inc. returns 2.8% to shareholders annually — split between a 0.5% dividend yield and 2.3% buyback yield. The payout ratio of 16.9% is conservative, leaving significant room for dividend growth or reinvestment. The earnings yield of 3.0% (inverse of P/E) provides a useful comparison to bond yields when assessing the stock's relative attractiveness to fixed income.
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | 0.5% | 0.4% | 0.3% | 0.3% | 0.3% | 0.1% | — | — | — | — | — |
| Payout Ratio | 16.9% | 16.9% | 12.8% | 11.9% | 30.8% | 14.4% | — | — | — | — | — |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 3.0% | 2.5% | 2.4% | 2.5% | 1.0% | 0.9% | — | — | — | — | — |
| FCF Yield | 5.4% | 4.4% | 3.3% | 1.4% | 1.4% | 0.4% | 0.8% | 0.9% | — | — | — |
| Buyback Yield | 2.3% | 1.8% | 0.0% | 0.1% | 0.1% | 0.1% | 0.0% | 0.0% | — | — | — |
| Total Shareholder Yield | 2.8% | 2.3% | 0.3% | 0.4% | 0.5% | 0.2% | 0.0% | 0.0% | — | — | — |
| Shares Outstanding | — | $496M | $498M | $497M | $494M | $493M | $489M | $488M | $489M | $489M | $489M |
Compare ALC with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
| $32B | 32.9 | 13.9 | 18.4 | 55.2% | 13.1% | 4.5% | 4.0% | 2.1 | |
| $10B | -11.2 | 27.0 | 31.4 | 30.1% | -2.7% | -14.6% | -1.4% | 14.9 | |
| $9B | 24.1 | 11.7 | 15.8 | 29.1% | 5.7% | 8.3% | 7.1% | 3.4 | |
| $17B | 30.5 | 17.4 | 18.4 | 61.0% | 17.4% | 11.1% | 9.4% | 2.6 | |
| $43B | 41.7 | 30.2 | 41.1 | 61.8% | 31.6% | 66.2% | 42.5% | 0.7 | |
| $50B | 46.9 | 26.4 | 37.1 | 78.1% | 27.0% | 10.5% | 15.5% | 0.4 | |
| $20B | 25.3 | 19.2 | 20.2 | 44.2% | 18.6% | 11.4% | 9.5% | 1.8 | |
| $557B | 39.9 | 19.3 | 28.1 | 69.1% | 24.9% | 20.1% | 20.7% | 1.2 | |
| $153B | 11.5 | 16.0 | 24.0 | 50.8% | 16.3% | 30.9% | 9.9% | 1.5 | |
| $13B | 35.0 | 14.0 | 29.4 | 60.7% | 16.7% | 4.6% | 4.8% | 2.5 | |
| $4B | 91.1 | 13.6 | 18.0 | 55.0% | 8.3% | 1.6% | 4.8% | 5.0 | |
| Healthcare Median | — | 22.1 | 14.2 | 18.4 | 63.9% | -4.4% | -33.2% | -11.7% | 3.2 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Includes 30+ ratios · 11 years · Updated daily
Deep dive into ALC consensus models and risk factors.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying ALC stock.
Alcon Inc.'s current P/E ratio is 32.9x. The historical average is 67.3x.
Alcon Inc.'s current EV/EBITDA is 13.9x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 21.7x.
Alcon Inc.'s return on equity (ROE) is 4.5%. The historical average is 1.1%.
Based on historical data, Alcon Inc. is trading at a P/E of 32.9x. Compare with industry peers and growth rates for a complete picture.
Alcon Inc.'s current dividend yield is 0.51% with a payout ratio of 16.9%.
Alcon Inc. has 55.2% gross margin and 13.1% operating margin. Operating margin between 10-20% is typical for established companies.
Alcon Inc.'s Debt/EBITDA ratio is 2.1x, indicating moderate leverage. A ratio between 2-4x is manageable but warrants monitoring.